CDK9 and colorectal carcinoma: As CDK9 plays such a critical role in the transcription of a number of oncogenes (Krystof et al., 2012; Lam et al., 2001; Wang and Fischer, 2008), targeting CDK9 may provide a promising therapeutic strategy for the treatment of CRC.